Purchases and Sales Made in Q2 2022 in Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS) during Q2 2022. The information is specifically focused on institutions that hold shares of Aclaris Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jul 27, 2022
Q2 2022
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-214K- 42.25% |
$2.18M - $3.66M
|
293K
$1.12M
|
|
|
Aug 11, 2022
Q2 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-292K- 19.93% |
$2.97M - $4.99M
|
1.17M
$4.49M
|
|
|
Aug 12, 2022
Q2 2022
|
Parkman Healthcare Partners LLC
Stamford, CT |
SELL
|
- |
-363K- 54.37% |
$3.69M - $6.2M
|
305K
$1.16M
|
|
|
Aug 15, 2022
Q2 2022
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-543K- 23.85% |
$5.52M - $9.28M
|
1.73M
$6.62M
|
|
|
Aug 15, 2022
Q2 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-829K- 14.47% |
$8.42M - $14.2M
|
4.9M
$18.7M
|